Zurcher Kantonalbank Zurich Cantonalbank cut its holdings in shares of CME Group Inc (NASDAQ:CME) by 1.0% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 74,110 shares of the financial services provider’s stock after selling 768 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in CME Group were worth $14,385,000 at the end of the most recent quarter.
Several other hedge funds have also bought and sold shares of the business. Advantage Investment Management LLC increased its stake in shares of CME Group by 119.0% in the second quarter. Advantage Investment Management LLC now owns 184 shares of the financial services provider’s stock worth $36,000 after buying an additional 100 shares during the period. 1ST Source Bank increased its stake in shares of CME Group by 6.8% in the second quarter. 1ST Source Bank now owns 1,846 shares of the financial services provider’s stock worth $358,000 after buying an additional 118 shares during the period. Fulcrum Capital LLC increased its stake in shares of CME Group by 0.4% in the second quarter. Fulcrum Capital LLC now owns 38,975 shares of the financial services provider’s stock worth $7,565,000 after buying an additional 146 shares during the period. Boston Common Asset Management LLC increased its stake in shares of CME Group by 27.6% in the second quarter. Boston Common Asset Management LLC now owns 46,710 shares of the financial services provider’s stock worth $9,067,000 after buying an additional 10,093 shares during the period. Finally, Advisor Partners LLC increased its stake in shares of CME Group by 6.4% in the second quarter. Advisor Partners LLC now owns 8,166 shares of the financial services provider’s stock worth $1,585,000 after buying an additional 492 shares during the period. 84.58% of the stock is currently owned by hedge funds and other institutional investors.
In other news, insider Sunil Cutinho sold 1,990 shares of the business’s stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $202.38, for a total transaction of $402,736.20. Following the sale, the insider now owns 31,182 shares in the company, valued at approximately $6,310,613.16. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Kathleen M. Cronin sold 4,960 shares of the business’s stock in a transaction on Tuesday, May 21st. The shares were sold at an average price of $186.69, for a total transaction of $925,982.40. Following the sale, the insider now owns 49,337 shares in the company, valued at approximately $9,210,724.53. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 80,863 shares of company stock worth $16,110,535. Company insiders own 1.20% of the company’s stock.
CME Group stock traded up $4.62 during mid-day trading on Friday, reaching $215.72. 879,352 shares of the company traded hands, compared to its average volume of 1,366,583. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.05 and a quick ratio of 1.04. The stock’s 50 day moving average price is $202.16. The stock has a market capitalization of $75.37 billion, a price-to-earnings ratio of 31.63, a price-to-earnings-growth ratio of 4.71 and a beta of 0.23. CME Group Inc has a 52-week low of $161.05 and a 52-week high of $216.73.
CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.75 by $0.01. The business had revenue of $1.27 billion for the quarter, compared to the consensus estimate of $1.27 billion. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The company’s quarterly revenue was up 20.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.74 EPS. As a group, analysts anticipate that CME Group Inc will post 6.66 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Tuesday, September 10th will be issued a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.39%. The ex-dividend date of this dividend is Monday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 43.99%.
CME Group Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Featured Article: How Do You Calculate Return on Equity (ROE)?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.